189 related articles for article (PubMed ID: 29777136)
1. Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease.
Denadai-Souza A; Bonnart C; Tapias NS; Marcellin M; Gilmore B; Alric L; Bonnet D; Burlet-Schiltz O; Hollenberg MD; Vergnolle N; Deraison C
Sci Rep; 2018 May; 8(1):7834. PubMed ID: 29777136
[TBL] [Abstract][Full Text] [Related]
2. Intestinal protease-activated receptor-2 and fecal serine protease activity are increased in canine inflammatory bowel disease and may contribute to intestinal cytokine expression.
Maeda S; Ohno K; Uchida K; Igarashi H; Goto-Koshino Y; Fujino Y; Tsujimoto H
J Vet Med Sci; 2014 Aug; 76(8):1119-27. PubMed ID: 24829081
[TBL] [Abstract][Full Text] [Related]
3. Fecal Serine Protease Profiling in Inflammatory Bowel Diseases.
Jablaoui A; Kriaa A; Mkaouar H; Akermi N; Soussou S; Wysocka M; Wołoszyn D; Amouri A; Gargouri A; Maguin E; Lesner A; Rhimi M
Front Cell Infect Microbiol; 2020; 10():21. PubMed ID: 32117798
[TBL] [Abstract][Full Text] [Related]
4. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation.
Kriaa A; Jablaoui A; Mkaouar H; Akermi N; Maguin E; Rhimi M
FASEB J; 2020 Jun; 34(6):7270-7282. PubMed ID: 32307770
[TBL] [Abstract][Full Text] [Related]
5. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration.
Chin AC; Lee WY; Nusrat A; Vergnolle N; Parkos CA
J Immunol; 2008 Oct; 181(8):5702-10. PubMed ID: 18832729
[TBL] [Abstract][Full Text] [Related]
7. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
Buhner S; Hahne H; Hartwig K; Li Q; Vignali S; Ostertag D; Meng C; Hörmannsperger G; Braak B; Pehl C; Frieling T; Barbara G; De Giorgio R; Demir IE; Ceyhan GO; Zeller F; Boeckxstaens G; Haller D; Kuster B; Schemann M
PLoS One; 2018; 13(3):e0193943. PubMed ID: 29529042
[TBL] [Abstract][Full Text] [Related]
8. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.
Mkaouar H; Akermi N; Mariaule V; Boudebbouze S; Gaci N; Szukala F; Pons N; Marquez J; Gargouri A; Maguin E; Rhimi M
Microb Cell Fact; 2016 Nov; 15(1):201. PubMed ID: 27894344
[TBL] [Abstract][Full Text] [Related]
9. Serine proteases in schistosomes and other trematodes.
Dvorak J; Horn M
Int J Parasitol; 2018 Apr; 48(5):333-344. PubMed ID: 29477711
[TBL] [Abstract][Full Text] [Related]
10. A critical review on serine protease: Key immune manipulator and pathology mediator.
Patel S
Allergol Immunopathol (Madr); 2017; 45(6):579-591. PubMed ID: 28236540
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors and activity-based probes targeting serine proteases.
Ferguson TEG; Reihill JA; Martin SL; Walker B
Front Chem; 2022; 10():1006618. PubMed ID: 36247662
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of IL-16 in inflammatory bowel disease.
Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
[TBL] [Abstract][Full Text] [Related]
13. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
14. Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo.
Glenthøj A; Nickles K; Cowland J; Borregaard N
PLoS One; 2015; 10(5):e0125483. PubMed ID: 25945506
[TBL] [Abstract][Full Text] [Related]
15. Proteasuria in nephrotic syndrome-quantification and proteomic profiling.
Wörn M; Bohnert BN; Alenazi F; Boldt K; Klose F; Junger K; Ueffing M; Birkenfeld AL; Kalbacher H; Artunc F
J Proteomics; 2021 Jan; 230():103981. PubMed ID: 32927112
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
Bai AH; Wu WK; Xu L; Wong SH; Go MY; Chan AW; Harbord M; Zhang S; Chen M; Wu JC; Chan MW; Chan MT; Chan FK; Sung JJ; Yu J; Cheng AS; Ng SC
J Crohns Colitis; 2016 Jun; 10(6):726-34. PubMed ID: 26802082
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.
Mayers MD; Moon C; Stupp GS; Su AI; Wolan DW
J Proteome Res; 2017 Feb; 16(2):1014-1026. PubMed ID: 28052195
[TBL] [Abstract][Full Text] [Related]
18. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
Costello CM; Mah N; Häsler R; Rosenstiel P; Waetzig GH; Hahn A; Lu T; Gurbuz Y; Nikolaus S; Albrecht M; Hampe J; Lucius R; Klöppel G; Eickhoff H; Lehrach H; Lengauer T; Schreiber S
PLoS Med; 2005 Aug; 2(8):e199. PubMed ID: 16107186
[TBL] [Abstract][Full Text] [Related]
19. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease.
Heimerl S; Moehle C; Zahn A; Boettcher A; Stremmel W; Langmann T; Schmitz G
Biochim Biophys Acta; 2006 Mar; 1762(3):341-50. PubMed ID: 16439103
[TBL] [Abstract][Full Text] [Related]
20. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
